273 related articles for article (PubMed ID: 21350583)
1. Targeting tyrosine kinases and autophagy in prostate cancer.
Kung HJ
Horm Cancer; 2011 Feb; 2(1):38-46. PubMed ID: 21350583
[TBL] [Abstract][Full Text] [Related]
2. Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.
Liu Y; Karaca M; Zhang Z; Gioeli D; Earp HS; Whang YE
Oncogene; 2010 Jun; 29(22):3208-16. PubMed ID: 20383201
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.
Lee LF; Guan J; Qiu Y; Kung HJ
Mol Cell Biol; 2001 Dec; 21(24):8385-97. PubMed ID: 11713275
[TBL] [Abstract][Full Text] [Related]
4. Compensatory upregulation of tyrosine kinase Etk/BMX in response to androgen deprivation promotes castration-resistant growth of prostate cancer cells.
Dai B; Chen H; Guo S; Yang X; Linn DE; Sun F; Li W; Guo Z; Xu K; Kim O; Kong X; Melamed J; Qiu S; Chen H; Qiu Y
Cancer Res; 2010 Jul; 70(13):5587-96. PubMed ID: 20570899
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.
Lee LF; Louie MC; Desai SJ; Yang J; Chen HW; Evans CP; Kung HJ
Oncogene; 2004 Mar; 23(12):2197-205. PubMed ID: 14767470
[TBL] [Abstract][Full Text] [Related]
6. Autophagy Blockade Sensitizes Prostate Cancer Cells towards Src Family Kinase Inhibitors.
Wu Z; Chang PC; Yang JC; Chu CY; Wang LY; Chen NT; Ma AH; Desai SJ; Lo SH; Evans CP; Lam KS; Kung HJ
Genes Cancer; 2010 Jan; 1(1):40-9. PubMed ID: 20811583
[TBL] [Abstract][Full Text] [Related]
7. Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancer.
Yang JC; Ok JH; Busby JE; Borowsky AD; Kung HJ; Evans CP
Cancer Res; 2009 Jan; 69(1):151-60. PubMed ID: 19117998
[TBL] [Abstract][Full Text] [Related]
8. CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors.
Guo W; Liu R; Bhardwaj G; Ma AH; Changou C; Yang JC; Li Y; Feng C; Luo Y; Mazloom A; Sanchez E; Wang Y; Huang W; Patterson R; Evans CP; Lam KS; Kung HJ
PLoS One; 2013; 8(8):e70910. PubMed ID: 23967135
[TBL] [Abstract][Full Text] [Related]
9. Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor.
Guo W; Liu R; Bhardwaj G; Yang JC; Changou C; Ma AH; Mazloom A; Chintapalli S; Xiao K; Xiao W; Kumaresan P; Sanchez E; Yeh CT; Evans CP; Patterson R; Lam KS; Kung HJ
Cell Death Dis; 2014 Sep; 5(9):e1409. PubMed ID: 25188519
[TBL] [Abstract][Full Text] [Related]
10. Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors.
Guyader C; CĂ©raline J; Gravier E; Morin A; Michel S; Erdmann E; de Pinieux G; Cabon F; Bergerat JP; Poupon MF; Oudard S
PLoS One; 2012; 7(8):e42252. PubMed ID: 22879924
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic activation of androgen receptor.
Kung HJ; Evans CP
Urol Oncol; 2009; 27(1):48-52. PubMed ID: 19111798
[TBL] [Abstract][Full Text] [Related]
12. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.
Mahajan NP; Liu Y; Majumder S; Warren MR; Parker CE; Mohler JL; Earp HS; Whang YE
Proc Natl Acad Sci U S A; 2007 May; 104(20):8438-43. PubMed ID: 17494760
[TBL] [Abstract][Full Text] [Related]
13. Synergism of cytoplasmic kinases in IL6-induced ligand-independent activation of androgen receptor in prostate cancer cells.
Kim O; Jiang T; Xie Y; Guo Z; Chen H; Qiu Y
Oncogene; 2004 Mar; 23(10):1838-44. PubMed ID: 14981536
[TBL] [Abstract][Full Text] [Related]
14. Differential requirement for Src family tyrosine kinases in the initiation, progression, and metastasis of prostate cancer.
Gelman IH; Peresie J; Eng KH; Foster BA
Mol Cancer Res; 2014 Oct; 12(10):1470-9. PubMed ID: 25053806
[TBL] [Abstract][Full Text] [Related]
15. High-Content Screening Identifies Src Family Kinases as Potential Regulators of AR-V7 Expression and Androgen-Independent Cell Growth.
Szafran AT; Stephan C; Bolt M; Mancini MG; Marcelli M; Mancini MA
Prostate; 2017 Jan; 77(1):82-93. PubMed ID: 27699828
[TBL] [Abstract][Full Text] [Related]
16. Activation of nonreceptor tyrosine kinase Bmx/Etk mediated by phosphoinositide 3-kinase, epidermal growth factor receptor, and ErbB3 in prostate cancer cells.
Jiang X; Borgesi RA; McKnight NC; Kaur R; Carpenter CL; Balk SP
J Biol Chem; 2007 Nov; 282(45):32689-98. PubMed ID: 17823122
[TBL] [Abstract][Full Text] [Related]
17. c-Src, Insulin-Like Growth Factor I Receptor, G-Protein-Coupled Receptor Kinases and Focal Adhesion Kinase are Enriched Into Prostate Cancer Cell Exosomes.
DeRita RM; Zerlanko B; Singh A; Lu H; Iozzo RV; Benovic JL; Languino LR
J Cell Biochem; 2017 Jan; 118(1):66-73. PubMed ID: 27232975
[TBL] [Abstract][Full Text] [Related]
18. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
19. Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer.
Mirkheshti N; Park S; Jiang S; Cropper J; Werner SL; Song CS; Chatterjee B
Oncotarget; 2016 Sep; 7(38):62240-62254. PubMed ID: 27557496
[TBL] [Abstract][Full Text] [Related]
20. The role of DOC-2/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer.
Zhoul J; Hernandez G; Tu SW; Huang CL; Tseng CP; Hsieh JT
Cancer Res; 2005 Nov; 65(21):9906-13. PubMed ID: 16267015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]